|
The manufacturer was contacted in reference to the voluntary field safety notice/recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The manufacturer received information that the patient alleging upper respiratory infection.There was no report of medical intervention.The manufacturer was made aware of this complaint through a representative of the customer.The device was returned to the manufacturer's quality product investigation laboratory for investigation.The manufacture inspected and observed dust/dirt contamination inconsistent with degraded sound abatement foam was observed throughout device enclosure, and airpath, suggesting a source external to the device.Slight black contamination at the blower seal of the blower box is consistent with the keratin contamination observed.The manufacturer was not observed the sound abatement foam degradation/breakdown.The device's event logs were downloaded and reviewed by manufacturer.The manufacturer found no error codes.The manufacturer applied power to the device and verified airflow.The manufacturer concludes there was no evidence of sound abatement foam degradation.The manufacturer observed dust contamination and unable to address the symptoms described.Manufacturer can confirm the presence of contamination in the airpath.
|